Map3k7 (mitogen activated protein kinase kinase kinase 7) - Rat Genome Database

Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Map3k7 (mitogen activated protein kinase kinase kinase 7) Rattus norvegicus
Symbol: Map3k7
Name: mitogen activated protein kinase kinase kinase 7
RGD ID: 1309438
Description: Enables several functions, including ATP binding activity; enzyme binding activity; and protein kinase activity. Involved in several processes, including cellular response to oxygen-glucose deprivation; positive regulation of intracellular signal transduction; and positive regulation of vascular associated smooth muscle cell migration. Predicted to be located in cytosol; plasma membrane; and postsynaptic density. Predicted to be part of ATAC complex. Predicted to be active in cytoplasm. Human ortholog(s) of this gene implicated in frontometaphyseal dysplasia 2 and prostate cancer. Orthologous to human MAP3K7 (mitogen-activated protein kinase kinase kinase 7); PARTICIPATES IN p38 MAPK signaling pathway; Bone morphogenetic proteins signaling pathway; c-Jun N-terminal kinases MAPK signaling pathway; INTERACTS WITH 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine; 2,6-dinitrotoluene.
Type: protein-coding
RefSeq Status: VALIDATED
Previously known as: LOC100910771; mitogen-activated protein kinase kinase kinase 7; mitogen-activated protein kinase kinase kinase 7-like; Tak1; TGF-beta activated kinase 1
RGD Orthologs
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Rat AssemblyChrPosition (strand)SourceGenome Browsers
mRatBN7.2546,356,973 - 46,415,597 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl546,357,931 - 46,415,597 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx548,494,947 - 48,552,846 (+)NCBIRnor_SHR
UTH_Rnor_SHRSP_BbbUtx_1.0550,094,119 - 50,152,018 (+)NCBIRnor_SHRSP
UTH_Rnor_WKY_Bbb_1.0550,043,393 - 50,101,289 (+)NCBIRnor_WKY
Rnor_6.0547,183,142 - 47,244,424 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl547,186,558 - 47,244,416 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_6.0 Ensembl9114,022,137 - 114,079,089 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.0551,793,737 - 51,852,677 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4548,252,637 - 48,308,820 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.1548,252,815 - 48,309,011 (+)NCBI
Celera545,121,067 - 45,178,378 (+)NCBICelera
Cytogenetic Map5q21NCBI
JBrowse: View Region in Genome Browser (JBrowse)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(-)-demecolcine  (ISO)
(1->4)-beta-D-glucan  (ISO)
1,2-dimethylhydrazine  (ISO)
17beta-estradiol  (EXP)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,6-dinitrotoluene  (EXP)
2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid  (ISO)
2-hydroxypropanoic acid  (ISO)
5Z-7-oxozeaenol  (ISO)
actinomycin D  (ISO)
aflatoxin B1  (ISO)
AICA ribonucleotide  (EXP)
albiflorin  (ISO)
alpha-Chaconine  (ISO)
angiotensin II  (ISO)
antirheumatic drug  (ISO)
arjunolic acid  (EXP)
benzo[a]pyrene  (ISO)
bis(2-chloroethyl) sulfide  (ISO)
bisphenol A  (EXP,ISO)
cadmium atom  (EXP)
cadmium dichloride  (EXP,ISO)
camptothecin  (ISO)
cannabidiol  (ISO)
capsaicin  (ISO)
capsazepine  (ISO)
carbamazepine  (ISO)
carbon nanotube  (ISO)
casticin  (ISO)
CGP 52608  (ISO)
cisplatin  (EXP)
corticosterone  (EXP)
cortisol  (ISO)
coumarin  (ISO)
cyclosporin A  (ISO)
dibutyl phthalate  (ISO)
diclofenac  (ISO)
dihydrolipoic acid  (EXP)
disodium selenite  (ISO)
dorsomorphin  (ISO)
doxorubicin  (EXP,ISO)
elemental selenium  (ISO)
ethanol  (ISO)
fasudil  (ISO)
filipin III  (EXP)
flutamide  (EXP)
formaldehyde  (ISO)
hexadecanoic acid  (EXP)
hypochlorous acid  (ISO)
iron atom  (EXP)
iron(0)  (EXP)
iron(2+) sulfate (anhydrous)  (EXP)
kaempferol  (ISO)
lipopolysaccharide  (ISO)
manganese(II) chloride  (ISO)
metformin  (EXP,ISO)
methamphetamine  (EXP)
methotrexate  (ISO)
methylparaben  (ISO)
monocrotaline  (EXP)
myricetin  (ISO)
N-phosphocreatine  (EXP)
nickel dichloride  (EXP)
nonanoic acid  (ISO)
o-anisidine  (ISO)
oligomycin  (EXP)
olmesartan  (EXP)
omega-3 fatty acid  (EXP)
oxazepam  (ISO)
oxidised LDL  (ISO)
paclitaxel  (ISO)
paeoniflorin  (EXP)
paracetamol  (ISO)
paraquat  (EXP,ISO)
Pentoxifylline  (EXP,ISO)
perfluorooctane-1-sulfonic acid  (ISO)
phenylephrine  (EXP)
phenylmercury acetate  (ISO)
phlorizin  (ISO)
pirinixic acid  (ISO)
quercetin  (ISO)
rac-lactic acid  (ISO)
reactive oxygen species  (ISO)
resveratrol  (ISO)
rosmarinic acid  (EXP)
SB 431542  (ISO)
selenium atom  (ISO)
silicon dioxide  (EXP)
simvastatin  (ISO)
sodium arsenite  (ISO)
sodium dichromate  (ISO)
sodium fluoride  (ISO)
sulfates  (ISO)
sunitinib  (ISO)
tacrolimus hydrate  (ISO)
tert-butyl hydroperoxide  (ISO)
testosterone  (EXP)
toluene 2,4-diisocyanate  (ISO)
tributylstannane  (EXP)
trichloroethene  (EXP)
trichostatin A  (ISO)
tunicamycin  (ISO)
valproic acid  (ISO)
vincristine  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
activation of NF-kappaB-inducing kinase activity  (ISO)
angiogenesis  (ISO)
anoikis  (ISO)
apoptotic process  (IEA)
apoptotic signaling pathway  (ISO)
bone development  (ISO)
cellular response to angiotensin  (IDA)
cellular response to oxygen-glucose deprivation  (IEP)
cellular response to transforming growth factor beta stimulus  (IDA,IEP)
cellular response to tumor necrosis factor  (IDA)
chromatin remodeling  (IEA)
histone H3 acetylation  (ISO)
I-kappaB kinase/NF-kappaB signaling  (ISO)
I-kappaB phosphorylation  (IEA,ISO,ISS)
inflammatory response  (ISO)
interleukin-17A-mediated signaling pathway  (ISO)
JNK cascade  (IBA,ISO,ISS)
MAPK cascade  (IDA,IEA,ISO)
negative regulation of apoptotic signaling pathway  (ISO)
negative regulation of gene expression  (IMP)
negative regulation of necroptotic process  (ISO)
negative regulation of reactive oxygen species metabolic process  (ISO)
negative regulation of ripoptosome assembly involved in necroptotic process  (ISO)
negative regulation of voltage-gated calcium channel activity  (IMP)
neural tube formation  (ISO)
osteoblast differentiation  (ISO)
peptidyl-threonine phosphorylation  (ISO)
positive regulation of autophagy  (IMP)
positive regulation of cell cycle  (IMP)
positive regulation of cell size  (IMP)
positive regulation of I-kappaB kinase/NF-kappaB signaling  (IBA,IMP,ISO)
positive regulation of interleukin-2 production  (ISO)
positive regulation of JNK cascade  (ISO)
positive regulation of JUN kinase activity  (IEA,ISO,ISS)
positive regulation of macroautophagy  (ISO)
positive regulation of MAPK cascade  (IDA)
positive regulation of T cell cytokine production  (ISO)
positive regulation of vascular associated smooth muscle cell migration  (IMP)
positive regulation of vascular associated smooth muscle cell proliferation  (IMP)
protein phosphorylation  (IDA,ISO)
regulation of reactive oxygen species metabolic process  (ISO)
response to angiotensin  (IEP)
response to hypoxia  (IEP)
stress-activated MAPK cascade  (ISO)
toll-like receptor 4 signaling pathway  (IEA,ISO)
transforming growth factor beta receptor signaling pathway  (ISO)

Cellular Component


References - curated
# Reference Title Reference Citation
1. Arjunolic acid, a peroxisome proliferator-activated receptor α agonist, regresses cardiac fibrosis by inhibiting non-canonical TGF-β signaling. Bansal T, etal., J Biol Chem. 2017 Oct 6;292(40):16440-16462. doi: 10.1074/jbc.M117.788299. Epub 2017 Aug 18.
2. Tripartite Motif 8 Contributes to Pathological Cardiac Hypertrophy Through Enhancing Transforming Growth Factor β-Activated Kinase 1-Dependent Signaling Pathways. Chen L, etal., Hypertension. 2017 Feb;69(2):249-258. doi: 10.1161/HYPERTENSIONAHA.116.07741. Epub 2016 Dec 12.
3. Mechanisms and functions of p38 MAPK signalling. Cuadrado A and Nebreda AR, Biochem J. 2010 Aug 1;429(3):403-17. doi: 10.1042/BJ20100323.
4. p38 MAP-kinases pathway regulation, function and role in human diseases. Cuenda A and Rousseau S, Biochim Biophys Acta. 2007 Aug;1773(8):1358-75. Epub 2007 Mar 24.
5. Tumor necrosis factor receptor-associated factor-6 and ribosomal S6 kinase intracellular pathways link the angiotensin II AT1 receptor to the phosphorylation and activation of the IkappaB kinase complex in vascular smooth muscle cells. Doyon P and Servant MJ, J Biol Chem. 2010 Oct 1;285(40):30708-18. doi: 10.1074/jbc.M110.126433. Epub 2010 Jul 21.
6. Growth/differentiation factor 15 causes TGFβ-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertension. Garfield BE, etal., Thorax. 2019 Feb;74(2):164-176. doi: 10.1136/thoraxjnl-2017-211440. Epub 2018 Dec 15.
7. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
8. Erythropoietin Abrogates Post-Ischemic Activation of the NLRP3, NLRC4, and AIM2 Inflammasomes in Microglia/Macrophages in a TAK1-Dependent Manner. Heinisch O, etal., Transl Stroke Res. 2022 Jun;13(3):462-482. doi: 10.1007/s12975-021-00948-8. Epub 2021 Oct 9.
9. FBXW5 acts as a negative regulator of pathological cardiac hypertrophy by decreasing the TAK1 signaling to pro-hypertrophic members of the MAPK signaling pathway. Hui X, etal., J Mol Cell Cardiol. 2021 Feb;151:31-43. doi: 10.1016/j.yjmcc.2020.09.008. Epub 2020 Sep 22.
10. The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling. Ji YX, etal., Nat Commun. 2016 Jun 1;7:11267. doi: 10.1038/ncomms11267.
11. The c-jun kinase/stress-activated pathway: regulation, function and role in human disease. Johnson GL and Nakamura K, Biochim Biophys Acta. 2007 Aug;1773(8):1341-8. Epub 2007 Jan 4.
12. Genetic mapping of allelic loss on chromosome 6q within heterogeneous prostate carcinoma. Konishi N, etal., Cancer Sci. 2003 Sep;94(9):764-8.
13. Pathogen recognition by the innate immune system. Kumar H, etal., Int Rev Immunol. 2011 Feb;30(1):16-34.
14. Modulation of AT-1R/AMPK-MAPK cascade plays crucial role for the pathogenesis of diabetic cardiomyopathy in transgenic type 2 diabetic (Spontaneous Diabetic Torii) rats. Lakshmanan AP, etal., Biochem Pharmacol. 2012 Mar 1;83(5):653-60. doi: 10.1016/j.bcp.2011.11.018. Epub 2011 Nov 28.
15. Heterozygous Mutations in MAP3K7, Encoding TGF-beta-Activated Kinase 1, Cause Cardiospondylocarpofacial Syndrome. Le Goff C, etal., Am J Hum Genet. 2016 Aug 4;99(2):407-13. doi: 10.1016/j.ajhg.2016.06.005. Epub 2016 Jul 14.
16. Farnesoid X receptor activation inhibits TGFBR1/TAK1-mediated vascular inflammation and calcification via miR-135a-5p. Li C, etal., Commun Biol. 2020 Jun 24;3(1):327. doi: 10.1038/s42003-020-1058-2.
17. Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling pathway. Li CY, etal., Basic Res Cardiol. 2016 Mar;111(2):19. doi: 10.1007/s00395-016-0536-7. Epub 2016 Feb 18.
18. GCN5-mediated regulation of pathological cardiac hypertrophy via activation of the TAK1-JNK/p38 signaling pathway. Li J, etal., Cell Death Dis. 2022 Apr 30;13(4):421. doi: 10.1038/s41419-022-04881-y.
19. Transforming growth factor beta-activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling. Li L, etal., Circulation. 2014 Dec 9;130(24):2162-72. doi: 10.1161/CIRCULATIONAHA.114.011195. Epub 2014 Oct 2.
20. microRNA-149-5p mediates the PM2.5-induced inflammatory response by targeting TAB2 via MAPK and NF-κB signaling pathways in vivo and in vitro. Li Q, etal., Cell Biol Toxicol. 2021 Jul 31. pii: 10.1007/s10565-021-09638-5. doi: 10.1007/s10565-021-09638-5.
21. Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway. Liao HH, etal., Oxid Med Cell Longev. 2019 Dec 6;2019:6304058. doi: 10.1155/2019/6304058. eCollection 2019.
22. TGF-beta1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activation. Lim JY, etal., J Mol Cell Cardiol. 2005 Oct;39(4):627-36. doi: 10.1016/j.yjmcc.2005.06.016.
23. Expanding role of ubiquitination in NF-kappaB signaling. Liu S and Chen ZJ, Cell Res. 2011 Jan;21(1):6-21. Epub 2010 Dec 7.
24. MG53, A Novel Regulator of KChIP2 and Ito,f, Plays a Critical Role in Electrophysiological Remodeling in Cardiac Hypertrophy. Liu W, etal., Circulation. 2019 Apr 30;139(18):2142-2156. doi: 10.1161/CIRCULATIONAHA.118.029413.
25. Deletion of a small consensus region at 6q15, including the MAP3K7 gene, is significantly associated with high-grade prostate cancers. Liu W, etal., Clin Cancer Res. 2007 Sep 1;13(17):5028-33.
26. Leukotriene B4 Inhibits L-Type Calcium Channels via p38 Signaling Pathway in Vascular Smooth Muscle Cells. Liu X, etal., Cell Physiol Biochem. 2015;37(5):1903-13. doi: 10.1159/000438551. Epub 2015 Nov 17.
27. Albiflorin Alleviates Ox-LDL-Induced Human Umbilical Vein Endothelial Cell Injury through IRAK1/TAK1 Pathway. Liu Y, etal., Biomed Res Int. 2022 May 13;2022:6584645. doi: 10.1155/2022/6584645. eCollection 2022.
28. Inhibition of TGFβ-activated kinase 1 promotes inflammation-resolving microglial/macrophage responses and recovery after stroke in ovariectomized female mice. Liu Y, etal., Neurobiol Dis. 2021 Apr;151:105257. doi: 10.1016/j.nbd.2021.105257. Epub 2021 Jan 9.
29. C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice. Ma ZG, etal., Cardiovasc Res. 2019 May 1;115(6):1067-1077. doi: 10.1093/cvr/cvy279.
30. Biomechanical signals suppress TAK1 activation to inhibit NF-kappaB transcriptional activation in fibrochondrocytes. Madhavan S, etal., J Immunol. 2007 Nov 1;179(9):6246-54.
31. Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats. Matsumoto-Ida M, etal., Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H709-15. Epub 2005 Sep 23.
32. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
33. TAK1 kinase signaling regulates embryonic angiogenesis by modulating endothelial cell survival and migration. Morioka S, etal., Blood. 2012 Nov 1;120(18):3846-57. doi: 10.1182/blood-2012-03-416198. Epub 2012 Sep 12.
34. BMPR-II deficiency elicits pro-proliferative and anti-apoptotic responses through the activation of TGFβ-TAK1-MAPK pathways in PAH. Nasim MT, etal., Hum Mol Genet. 2012 Jun 1;21(11):2548-58. doi: 10.1093/hmg/dds073. Epub 2012 Mar 2.
35. Acute inhibition of TAK1 protects against neuronal death in cerebral ischemia. Neubert M, etal., Cell Death Differ. 2011 Sep;18(9):1521-30. doi: 10.1038/cdd.2011.29. Epub 2011 Apr 8.
36. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
37. PID Annotation Import Pipeline Pipeline to import Pathway Interaction Database annotations from NCI into RGD
38. GOA pipeline RGD automated data pipeline
39. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
40. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
41. Comprehensive gene review and curation RGD comprehensive gene curation
42. Brain endothelial TAK1 and NEMO safeguard the neurovascular unit. Ridder DA, etal., J Exp Med. 2015 Sep 21;212(10):1529-49. doi: 10.1084/jem.20150165. Epub 2015 Sep 7.
43. TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Verstrepen L, etal., Cell Mol Life Sci. 2008 Oct;65(19):2964-78.
44. Mutations in MAP3K7 that Alter the Activity of the TAK1 Signaling Complex Cause Frontometaphyseal Dysplasia. Wade EM, etal., Am J Hum Genet. 2016 Aug 4;99(2):392-406. doi: 10.1016/j.ajhg.2016.05.024. Epub 2016 Jul 15.
45. NG25, an inhibitor of transforming growth factor‑β‑activated kinase 1, ameliorates neuronal apoptosis in neonatal hypoxic‑ischemic rats. Wang H, etal., Mol Med Rep. 2018 Jan;17(1):1710-1716. doi: 10.3892/mmr.2017.8024. Epub 2017 Nov 10.
46. Transforming Growth Factor Beta-Activated Kinase 1-Dependent Microglial and Macrophage Responses Aggravate Long-Term Outcomes After Ischemic Stroke. Wang R, etal., Stroke. 2020 Mar;51(3):975-985. doi: 10.1161/STROKEAHA.119.028398. Epub 2020 Feb 12.
47. A direct interaction between TGFbeta activated kinase 1 and the TGFbeta type II receptor: implications for TGFbeta signalling and cardiac hypertrophy. Watkins SJ, etal., Cardiovasc Res. 2006 Feb 1;69(2):432-9. Epub 2005 Dec 19.
48. Interleukin-1 (IL-1) pathway. Weber A, etal., Sci Signal. 2010 Jan 19;3(105):cm1. doi: 10.1126/scisignal.3105cm1.
49. Olmesartan ameliorates pressure overload-induced cardiac remodeling through inhibition of TAK1/p38 signaling in mice. Wu L, etal., Life Sci. 2016 Jan 15;145:121-6. doi: 10.1016/j.lfs.2015.12.034. Epub 2015 Dec 17.
50. CARD3 Promotes Cerebral Ischemia-Reperfusion Injury Via Activation of TAK1. Wu X, etal., J Am Heart Assoc. 2020 May 5;9(9):e014920. doi: 10.1161/JAHA.119.014920. Epub 2020 Apr 30.
51. [Mobilization of Bone Marrow Mesenchymal Stem Cells Inhibits TGF-β Non-classical Pathway Against Myocardial Fibrosis in Rats]. Xia WQ, etal., Sichuan Da Xue Xue Bao Yi Xue Ban. 2020 May;51(3):344-349. doi: 10.12182/20200560503.
52. Simvastatin ameliorates ventricular remodeling via the TGFbeta1 signaling pathway in rats following myocardial infarction. Xiao X, etal., Mol Med Rep. 2016 Apr 25. doi: 10.3892/mmr.2016.5178.
53. A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Xie M, etal., Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17378-83. doi: 10.1073/pnas.0604708103. Epub 2006 Nov 3.
54. A20 prevents obesity-induced development of cardiac dysfunction. Xu W, etal., J Mol Med (Berl). 2018 Feb;96(2):159-172. doi: 10.1007/s00109-017-1608-3. Epub 2017 Nov 16.
55. Sialyltransferase7A promotes angiotensin II-induced cardiomyocyte hypertrophy via HIF-1α-TAK1 signalling pathway. Yan X, etal., Cardiovasc Res. 2020 Jan 1;116(1):114-126. doi: 10.1093/cvr/cvz064.
56. Transforming growth factor β-activated kinase 1 negatively regulates interleukin-1α-induced stromal-derived factor-1 expression in vascular smooth muscle cells. Yang B, etal., Biochem Biophys Res Commun. 2015 Jul 17-24;463(1-2):130-6. doi: 10.1016/j.bbrc.2015.05.047. Epub 2015 May 20.
57. Overexpression of miR-146b-5p Ameliorates Neonatal Hypoxic Ischemic Encephalopathy by Inhibiting IRAK1/TRAF6/TAK1/NF-αB Signaling. Yang G and Zhao Y, Yonsei Med J. 2020 Aug;61(8):660-669. doi: 10.3349/ymj.2020.61.8.660.
58. Cardiomyocyte-Specific RIP2 Overexpression Exacerbated Pathologic Remodeling and Contributed to Spontaneous Cardiac Hypertrophy. Yang JJ, etal., Front Cell Dev Biol. 2021 Oct 18;9:688238. doi: 10.3389/fcell.2021.688238. eCollection 2021.
59. Creg in Hepatocytes Ameliorates Liver Ischemia/Reperfusion Injury in a TAK1-Dependent Manner in Mice. Yang L, etal., Hepatology. 2019 Jan;69(1):294-313. doi: 10.1002/hep.30203.
60. TAK1-AMPK Pathway in Macrophages Regulates Hypothyroid Atherosclerosis. Yang Y, etal., Cardiovasc Drugs Ther. 2021 Jun;35(3):599-612. doi: 10.1007/s10557-020-06996-w.
61. Inhibitory effects of omega-3 fatty acids on early brain injury after subarachnoid hemorrhage in rats: Possible involvement of G protein-coupled receptor 120/β-arrestin2/TGF-β activated kinase-1 binding protein-1 signaling pathway. Yin J, etal., Int J Biochem Cell Biol. 2016 Jun;75:11-22. doi: 10.1016/j.biocel.2016.03.008. Epub 2016 Mar 18.
62. Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-κB pathways. Yu M, etal., Int J Med Sci. 2022 Mar 28;19(4):681-694. doi: 10.7150/ijms.69289. eCollection 2022.
63. RNF207 exacerbates pathological cardiac hypertrophy via post-translational modification of TAB1. Yuan L, etal., Cardiovasc Res. 2022 Mar 30:cvac039. doi: 10.1093/cvr/cvac039.
64. Microglial-specific depletion of TAK1 is neuroprotective in the acute phase after ischemic stroke. Zeyen T, etal., J Mol Med (Berl). 2020 Jun;98(6):833-847. doi: 10.1007/s00109-020-01916-9. Epub 2020 May 7.
65. TGFβ-activated Kinase 1 (TAK1) Inhibition by 5Z-7-Oxozeaenol Attenuates Early Brain Injury after Experimental Subarachnoid Hemorrhage. Zhang D, etal., J Biol Chem. 2015 Aug 7;290(32):19900-9. doi: 10.1074/jbc.M115.636795. Epub 2015 Jun 22.
66. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Zhang D, etal., Nat Med. 2000 May;6(5):556-63. doi: 10.1038/75037.
67. The E3 ubiquitin ligase TRIM31 plays a critical role in hypertensive nephropathy by promoting proteasomal degradation of MAP3K7 in the TGF-β1 signaling pathway. Zhang J, etal., Cell Death Differ. 2022 Mar;29(3):556-567. doi: 10.1038/s41418-021-00874-0. Epub 2021 Sep 28.
68. TAK1 accelerates transplant arteriosclerosis in rat aortic allografts by inducing autophagy in vascular smooth muscle cells. Zheng X, etal., Atherosclerosis. 2022 Feb;343:10-19. doi: 10.1016/j.atherosclerosis.2022.01.009. Epub 2022 Jan 19.
69. USP4 deficiency exacerbates hepatic ischaemia/reperfusion injury via TAK1 signalling. Zhou J, etal., Clin Sci (Lond). 2019 Jan 30;133(2):335-349. doi: 10.1042/CS20180959. Print 2019 Jan 31.
70. Dihydrolipoic Acid Inhibits Lysosomal Rupture and NLRP3 Through Lysosome-Associated Membrane Protein-1/Calcium/Calmodulin-Dependent Protein Kinase II/TAK1 Pathways After Subarachnoid Hemorrhage in Rat. Zhou K, etal., Stroke. 2018 Jan;49(1):175-183. doi: 10.1161/STROKEAHA.117.018593.
71. TRAF3 mediates neuronal apoptosis in early brain injury following subarachnoid hemorrhage via targeting TAK1-dependent MAPKs and NF-κB pathways. Zhou Y, etal., Cell Death Dis. 2021 Jan 7;12(1):10. doi: 10.1038/s41419-020-03278-z.
Additional References at PubMed
PMID:8663074   PMID:9079627   PMID:10094049   PMID:10702308   PMID:11460167   PMID:12464436   PMID:12477932   PMID:12556533   PMID:12969270   PMID:14982987   PMID:15125833   PMID:15831522  
PMID:16145668   PMID:16157589   PMID:16260493   PMID:16556914   PMID:17114649   PMID:17209006   PMID:18293403   PMID:18762249   PMID:18838386   PMID:20538596   PMID:20615388   PMID:20730577  
PMID:21052097   PMID:21630459   PMID:22829592   PMID:23378049   PMID:23751595   PMID:23776175   PMID:23778976   PMID:27012613   PMID:28842570   PMID:29291351   PMID:29348267   PMID:30361391  
PMID:30367484   PMID:31028803   PMID:31953451   PMID:32798288   PMID:35696800   PMID:35842555   PMID:35982795   PMID:36279673  


Comparative Map Data
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
mRatBN7.2546,356,973 - 46,415,597 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl546,357,931 - 46,415,597 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx548,494,947 - 48,552,846 (+)NCBIRnor_SHR
UTH_Rnor_SHRSP_BbbUtx_1.0550,094,119 - 50,152,018 (+)NCBIRnor_SHRSP
UTH_Rnor_WKY_Bbb_1.0550,043,393 - 50,101,289 (+)NCBIRnor_WKY
Rnor_6.0547,183,142 - 47,244,424 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl547,186,558 - 47,244,416 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_6.0 Ensembl9114,022,137 - 114,079,089 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.0551,793,737 - 51,852,677 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4548,252,637 - 48,308,820 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.1548,252,815 - 48,309,011 (+)NCBI
Celera545,121,067 - 45,178,378 (+)NCBICelera
Cytogenetic Map5q21NCBI
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
GRCh38690,513,579 - 90,587,072 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p13 Ensembl690,513,573 - 90,587,086 (-)EnsemblGRCh38hg38GRCh38
GRCh37691,223,298 - 91,296,791 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 36691,282,074 - 91,353,628 (-)NCBINCBI36Build 36hg18NCBI36
Celera691,646,249 - 91,717,462 (-)NCBICelera
Cytogenetic Map6q15NCBI
HuRef688,442,517 - 88,515,844 (-)NCBIHuRef
CHM1_1691,320,725 - 91,394,113 (-)NCBICHM1_1
T2T-CHM13v2.0691,725,183 - 91,798,324 (-)NCBIT2T-CHM13v2.0
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
GRCm39431,963,659 - 32,023,470 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl431,964,097 - 32,023,467 (+)EnsemblGRCm39 Ensembl
GRCm38431,963,492 - 32,023,470 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl431,964,097 - 32,023,467 (+)EnsemblGRCm38mm10GRCm38
MGSCv37432,051,082 - 32,110,442 (+)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv36432,292,735 - 32,349,405 (+)NCBIMGSCv36mm8
Celera431,710,402 - 31,768,496 (+)NCBICelera
Cytogenetic Map4A5NCBI
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
ChiLan1.0 EnsemblNW_00495541117,177,335 - 17,229,957 (-)EnsemblChiLan1.0
ChiLan1.0NW_00495541117,177,335 - 17,229,957 (-)NCBIChiLan1.0ChiLan1.0
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
NHGRI_mPanPan16108,504,996 - 108,581,339 (-)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v0688,398,329 - 88,470,926 (-)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.1691,664,263 - 91,737,468 (-)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl691,664,263 - 91,737,468 (-)Ensemblpanpan1.1panPan2
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
CanFam3.11249,669,849 - 49,740,039 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl1249,672,389 - 49,739,850 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha1249,477,606 - 49,546,370 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.01250,481,094 - 50,549,843 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl1250,481,149 - 50,549,837 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.11249,798,234 - 49,867,173 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.01249,697,121 - 49,766,116 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.01249,887,662 - 49,956,849 (-)NCBIUU_Cfam_GSD_1.0
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
HiC_Itri_2NW_02440494684,634,746 - 84,697,875 (-)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_0049365101,772,971 - 1,837,765 (+)EnsemblSpeTri2.0
SpeTri2.0NW_0049365101,772,971 - 1,836,075 (+)NCBISpeTri2.0SpeTri2.0SpeTri2.0
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
Sscrofa11.1 Ensembl158,481,956 - 58,548,057 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.1158,482,046 - 58,548,087 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.2165,479,754 - 65,542,430 (-)NCBISscrofa10.2Sscrofa10.2susScr3
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
ChlSab1.11315,284,927 - 15,360,539 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl1315,284,923 - 15,360,832 (-)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_023666040191,671,798 - 191,744,917 (-)NCBIVero_WHO_p1.0Vero_WHO_p1.0
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
HetGla_female_1.0 EnsemblNW_0046247993,554,678 - 3,622,289 (+)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_0046247993,554,644 - 3,623,317 (+)NCBIHetGla_female_1.0HetGla 1.0hetGla2


Variants in Map3k7
221 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:904
Count of miRNA genes:298
Interacting mature miRNAs:384
Transcripts:ENSRNOT00000007654, ENSRNOT00000007657
Prediction methods:Microtar, Miranda
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (
For more information about miRGate, see PMID:25858286 or access the full paper here.

QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
1331756Rf34Renal function QTL 344.16275kidney blood vessel physiology trait (VT:0100012)absolute change in renal blood flow rate (CMO:0001168)5190450412Rat
70212Niddm25Non-insulin dependent diabetes mellitus QTL 253.54blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)51131345958Rat
1331771Rf35Renal function QTL 354.36965kidney blood vessel physiology trait (VT:0100012)absolute change in renal blood flow rate (CMO:0001168)572947086724018Rat
1576314Eutr1Estrogen induced uterine response QTL 1uterus integrity trait (VT:0010575)pyometritis severity score (CMO:0002009)52138965166875058Rat
8662454Vetf3Vascular elastic tissue fragility QTL 327.4artery integrity trait (VT:0010639)number of ruptures of the internal elastic lamina of the abdominal aorta and iliac arteries (CMO:0002562)5228222669540447Rat
1300117Hrtrt8Heart rate QTL 83.49heart pumping trait (VT:2000009)heart rate (CMO:0000002)5384401847869213Rat
61462Niddm10Non-insulin dependent diabetes mellitus QTL 103.90.001blood glucose amount (VT:0000188)plasma glucose level (CMO:0000042)5511215947171491Rat
2293666Bmd38Bone mineral density QTL 384.4femur size trait (VT:1000369)femoral neck cortical cross-sectional area (CMO:0001702)5894822853948228Rat
7394712Emca13Estrogen-induced mammary cancer QTL 13mammary gland integrity trait (VT:0010552)mammary tumor number (CMO:0000343)5982326699753708Rat
1641903Alcrsp3Alcohol response QTL 3response to alcohol trait (VT:0010489)duration of loss of righting reflex (CMO:0002289)51268928557689285Rat
634305Mamtr1Mammary tumor resistance QTL 10.0001mammary gland integrity trait (VT:0010552)mammary tumor number (CMO:0000343)512789751113558310Rat
1600358Mamtr5Mammary tumor resistance QTL 5mammary gland integrity trait (VT:0010552)mammary tumor number (CMO:0000343)51887394763873947Rat
1358353Srcrtb2Stress Responsive Cort Basal QTL 23.480.003blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)51887394774251464Rat
8552954Pigfal14Plasma insulin-like growth factor 1 level QTL 149blood insulin-like growth factor amount (VT:0010479)plasma insulin-like growth factor 1 level (CMO:0001299)52122674466226744Rat
1578767Stresp17Stress response QTL 174.30.01blood aldosterone amount (VT:0005346)plasma aldosterone level (CMO:0000551)52795544072955440Rat
1578776Stresp18Stress response QTL 182.9thymus mass (VT:0004954)thymus wet weight (CMO:0000855)52795544072955440Rat
6903292Stl28Serum triglyceride level QTL 282.60.0073blood triglyceride amount (VT:0002644)plasma triglyceride level (CMO:0000548)52851548973515489Rat
6903306Scl35Serum cholesterol QTL 352.60.0073blood cholesterol amount (VT:0000180)plasma total cholesterol level (CMO:0000585)52851548973515489Rat
2290448Scl54Serum cholesterol level QTL 542.93blood cholesterol amount (VT:0000180)plasma total cholesterol level (CMO:0000585)531663789131345958Rat
1598807Glom12Glomerulus QTL 122.7kidney glomerulus morphology trait (VT:0005325)index of glomerular damage (CMO:0001135)53321566578215665Rat
1298067Scl15Serum cholesterol level QTL 154.80.001blood cholesterol amount (VT:0000180)plasma total cholesterol level (CMO:0000585)53321566578215665Rat
1302786Kidm8Kidney mass QTL 828.15kidney mass (VT:0002707)both kidneys wet weight to body weight ratio (CMO:0000340)53321566578215665Rat
1576317Eutr2Estrogen induced uterine response QTL 20.01uterus integrity trait (VT:0010575)pyometritis severity score (CMO:0002009)534730116104251008Rat
2316959Gluco59Glucose level QTL 594.7blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)534944474113558310Rat
1641922Alcrsp8Alcohol response QTL 8alcohol metabolism trait (VT:0015089)blood ethanol level (CMO:0000535)53518915368564008Rat
1641912Alcrsp18Alcohol response QTL 18response to alcohol trait (VT:0010489)duration of loss of righting reflex (CMO:0002289)535189153141643988Rat
1549845Scl44Serum cholesterol level QTL 446blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)540128307148607290Rat
1331773Scl26Serum cholesterol level QTL 263.065blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)54372665686724018Rat
1331801Rf33Renal function QTL 334.149kidney blood vessel physiology trait (VT:0100012)absolute change in renal vascular resistance (CMO:0001900)543726656129132602Rat

Markers in Region
Rat AssemblyChrPosition (strand)SourceJBrowse
Cytogenetic Map5q32UniSTS
Cytogenetic Map13q24UniSTS
Cytogenetic Map6q32UniSTS
Cytogenetic Map17p12UniSTS
Cytogenetic Map16p14UniSTS
Cytogenetic Map13q26UniSTS
Cytogenetic Map10q22UniSTS
Cytogenetic Map7q11UniSTS
Cytogenetic Map8q24UniSTS
Cytogenetic Map5q21UniSTS
Cytogenetic Map4q24UniSTS
Cytogenetic Map2q11UniSTS
Cytogenetic Map1q54UniSTS
Cytogenetic Map1q36UniSTS
Cytogenetic Map18p11UniSTS
Cytogenetic Map13q13UniSTS
Cytogenetic Map10q24UniSTS
Cytogenetic Map8q31UniSTS
Cytogenetic Map3q21UniSTS
Cytogenetic Map13p13UniSTS
Cytogenetic Map1q21UniSTS
Cytogenetic Map11q23UniSTS
Cytogenetic Map10q31UniSTS
Cytogenetic Map16q12.2UniSTS
Cytogenetic Map3q24UniSTS
Cytogenetic Map5q36UniSTS
Cytogenetic Map3p13UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.2546,391,359 - 46,391,525 (+)MAPPERmRatBN7.2
Rnor_6.0547,220,180 - 47,220,345NCBIRnor6.0
Rnor_6.09114,055,103 - 114,055,268NCBIRnor6.0
Rnor_5.09113,573,073 - 113,573,238UniSTSRnor5.0
Rnor_5.0551,828,433 - 51,828,598UniSTSRnor5.0
RGSC_v3.4548,286,051 - 48,286,216UniSTSRGSC3.4
Celera545,154,141 - 45,154,306UniSTS
RH 3.4 Map5263.39UniSTS
Cytogenetic Map5q21UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.2546,415,264 - 46,415,453 (+)MAPPERmRatBN7.2
Rnor_6.0547,244,084 - 47,244,272NCBIRnor6.0
Rnor_6.09114,079,007 - 114,079,204NCBIRnor6.0
Rnor_5.09113,596,977 - 113,597,174UniSTSRnor5.0
Rnor_5.0551,852,337 - 51,852,525UniSTSRnor5.0
RGSC_v3.4548,309,955 - 48,310,143UniSTSRGSC3.4
Celera545,178,034 - 45,178,234UniSTS
RH 3.4 Map5260.4UniSTS
Cytogenetic Map5q21UniSTS


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system appendage
Low 3 36 52 36 19 36 2 4 74 35 39 11 2
Below cutoff 7 5 5 5 6 7 2 6


Reference Sequences
RefSeq Acc Id: ENSRNOT00000007654   ⟹   ENSRNOP00000007654
RefSeq Status:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl546,357,931 - 46,415,597 (+)Ensembl
Rnor_6.0 Ensembl547,186,558 - 47,244,416 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000007657   ⟹   ENSRNOP00000007657
RefSeq Status:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl546,357,931 - 46,415,597 (+)Ensembl
Rnor_6.0 Ensembl9114,022,137 - 114,079,089 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000098749   ⟹   ENSRNOP00000083011
RefSeq Status:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl546,357,931 - 46,415,597 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000109648   ⟹   ENSRNOP00000090653
RefSeq Status:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl546,357,931 - 46,412,886 (+)Ensembl
RefSeq Acc Id: NM_001107920   ⟹   NP_001101390
RefSeq Status: VALIDATED
Rat AssemblyChrPosition (strand)Source
mRatBN7.2546,357,931 - 46,415,597 (+)NCBI
Rnor_6.0547,186,558 - 47,244,416 (+)NCBI
Rnor_5.0551,793,737 - 51,852,677 (+)NCBI
RGSC_v3.4548,252,637 - 48,308,820 (+)RGD
Celera545,121,067 - 45,178,378 (+)NCBI
RefSeq Acc Id: XM_006237966   ⟹   XP_006238028
RefSeq Status:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2546,356,973 - 46,413,034 (+)NCBI
Rnor_6.0547,183,142 - 47,244,424 (+)NCBI
Rnor_5.0551,793,737 - 51,852,677 (+)NCBI
RefSeq Acc Id: XM_039109819   ⟹   XP_038965747
RefSeq Status:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2546,356,973 - 46,389,490 (+)NCBI
Protein Sequences
Protein RefSeqs NP_001101390 (Get FASTA)   NCBI Sequence Viewer  
  XP_006238028 (Get FASTA)   NCBI Sequence Viewer  
  XP_038965747 (Get FASTA)   NCBI Sequence Viewer  
GenBank Protein EDL98558 (Get FASTA)   NCBI Sequence Viewer  
  EDL98559 (Get FASTA)   NCBI Sequence Viewer  
  P0C8E4 (Get FASTA)   NCBI Sequence Viewer  
Reference Sequences
RefSeq Acc Id: NP_001101390   ⟸   NM_001107920
- UniProtKB: P0C8E4 (UniProtKB/Swiss-Prot)
- Sequence:
RefSeq Acc Id: XP_006238028   ⟸   XM_006237966
- Peptide Label: isoform X1
- UniProtKB: A0A8I6GA73 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: ENSRNOP00000007654   ⟸   ENSRNOT00000007654
RefSeq Acc Id: XP_038965747   ⟸   XM_039109819
- Peptide Label: isoform X2
RefSeq Acc Id: ENSRNOP00000007657   ⟸   ENSRNOT00000007657
RefSeq Acc Id: ENSRNOP00000090653   ⟸   ENSRNOT00000109648
RefSeq Acc Id: ENSRNOP00000083011   ⟸   ENSRNOT00000098749
Protein Domains
Protein kinase

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P0C8E4-F1-model_v2 AlphaFold P0C8E4 1-606 view protein structure


eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:1309438 AgrOrtholog
BioCyc Gene G2FUF-41739 BioCyc
Ensembl Genes ENSRNOG00000005724 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  ENSRNOG00000047516 Ensembl
Ensembl Protein ENSRNOP00000007654 ENTREZGENE
  ENSRNOP00000007654.4 UniProtKB/Swiss-Prot
  ENSRNOP00000007657.5 UniProtKB/TrEMBL
  ENSRNOP00000083011.1 UniProtKB/TrEMBL
  ENSRNOP00000090653.1 UniProtKB/TrEMBL
Ensembl Transcript ENSRNOT00000007654 ENTREZGENE
  ENSRNOT00000007654.6 UniProtKB/Swiss-Prot
  ENSRNOT00000007657.6 UniProtKB/TrEMBL
  ENSRNOT00000098749.1 UniProtKB/TrEMBL
  ENSRNOT00000109648.1 UniProtKB/TrEMBL
Gene3D-CATH Transferase(Phosphotransferase) domain 1 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
InterPro Kinase-like_dom_sf UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  MAPKKK7 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Prot_kinase_dom UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Protein_kinase_ATP_BS UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Ser-Thr/Tyr_kinase_cat_dom UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Ser/Thr_kinase_AS UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report rno:313121 UniProtKB/Swiss-Prot
  PTHR46716 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Pfam PK_Tyr_Ser-Thr UniProtKB/TrEMBL, UniProtKB/Swiss-Prot
PhenoGen Map3k7 PhenoGen
PIRSF MAPKKK7 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
SMART S_TKc UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Superfamily-SCOP SSF56112 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  M3K7_RAT UniProtKB/Swiss-Prot, ENTREZGENE

Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2021-03-09 Map3k7  mitogen activated protein kinase kinase kinase 7  LOC100910771  mitogen-activated protein kinase kinase kinase 7-like  Data Merged 737654 PROVISIONAL
2012-07-05 LOC100910771  mitogen-activated protein kinase kinase kinase 7-like      Symbol and Name status set to provisional 70820 PROVISIONAL
2008-04-30 Map3k7  mitogen activated protein kinase kinase kinase 7   Map3k7_predicted  mitogen activated protein kinase kinase kinase 7 (predicted)  'predicted' is removed 2292626 APPROVED
2005-01-12 Map3k7_predicted  mitogen activated protein kinase kinase kinase 7 (predicted)      Symbol and Name status set to approved 70820 APPROVED